Validation of a Stability-Indicating LC Method for Assay of Ezetimibe in Tablets and for Determination of Content Uniformity
- 5 December 2007
- journal article
- Published by Springer Science and Business Media LLC in Chromatographia
- Vol. 67 (1-2), 137-142
- https://doi.org/10.1365/s10337-007-0470-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assayJournal of Pharmaceutical and Biomedical Analysis, 2006
- Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Ezetimibe in Human Plasma and Pharmaceutical FormulationsChromatographia, 2006
- Validating Chromatographic MethodsPublished by Wiley ,2005
- Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2005
- Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemiaEuropean Heart Journal, 2003
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- Ezetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studiesClinical Therapeutics, 2001